---
title: "Ernexa Therapeutics Inc - May Offer Up To $50 Million Of Securities - SEC Filing"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/279241403.md"
datetime: "2026-03-16T10:06:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279241403.md)
  - [en](https://longbridge.com/en/news/279241403.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279241403.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/279241403.md) | [繁體中文](https://longbridge.com/zh-HK/news/279241403.md)


# Ernexa Therapeutics Inc - May Offer Up To $50 Million Of Securities - SEC Filing

March 16 (Reuters) - Ernexa Therapeutics Inc (ERNA.O) : \* ERNEXA THERAPEUTICS INC - MAY OFFER UP TO $50 MILLION OF SECURITIES - SEC FILING Source text: Further company coverage: (ERNA.O) ((

### 相关股票

- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/zh-CN/quote/PBE.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/zh-CN/quote/BBH.US.md)
- [Ernexa Therapeutics (ERNA.US)](https://longbridge.com/zh-CN/quote/ERNA.US.md)
- [Proshares Ultra Nasdaq Biotech (BIB.US)](https://longbridge.com/zh-CN/quote/BIB.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/zh-CN/quote/IBB.US.md)
- [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-CN/quote/FBT.US.md)
- [Invesco Nasdaq Biotechnology ETF (IBBQ.US)](https://longbridge.com/zh-CN/quote/IBBQ.US.md)
- [ALPS Medical Breakthrough (SBIO.US)](https://longbridge.com/zh-CN/quote/SBIO.US.md)
- [Direxion S&P Biotech Bull 3X (LABU.US)](https://longbridge.com/zh-CN/quote/LABU.US.md)
- [SPDR S&P Biotech (XBI.US)](https://longbridge.com/zh-CN/quote/XBI.US.md)

## 相关资讯与研究

- [Dyadic Applied Hikes on Integrated Pact](https://longbridge.com/zh-CN/news/279283757.md)
- [Oragenics receives HREC approval, begins Phase IIa ONP-002 site initiation in Australia](https://longbridge.com/zh-CN/news/278776483.md)
- [Sernova Biotherapeutics publishes MD&A for the three months ended Jan. 31, 2026 and 2025](https://longbridge.com/zh-CN/news/279276126.md)
- [Structure Therapeutics Reports Strong Phase 2 Obesity Drug Results](https://longbridge.com/zh-CN/news/279269040.md)
- [C-Further Unveils First Therapeutic Programmes Dedicated to Paediatric Oncology | INKT Stock News](https://longbridge.com/zh-CN/news/278521475.md)